Authors:
Fisker, S
Norrelund, H
Juul, A
Skakkebaek, NE
Christiansen, JS
Jorgensen, JOL
Citation: S. Fisker et al., The growth hormone (GH)-insulin-like growth factor axis during testosterone replacement therapy in GH-treated hypopituitary males, GROWTH H I, 11(2), 2001, pp. 104-109
Authors:
Norrelund, H
Moller, N
Nair, KS
Christiansen, JS
Jorgensen, JOL
Citation: H. Norrelund et al., Continuation of growth hormone (GH) substitution during fasting in GH-deficient patients decreases urea excretion and conserves protein synthesis, J CLIN END, 86(7), 2001, pp. 3120-3129
Authors:
Norrelund, H
Nair, KS
Jorgensen, JOL
Christiansen, JS
Moller, N
Citation: H. Norrelund et al., The protein-retaining effects of growth hormone during fasting involve inhibition of muscle-protein breakdown, DIABETES, 50(1), 2001, pp. 96-104
Authors:
Conceicao, FL
Jorgensen, JOL
Vahl, N
Norrelund, H
Christiansen, JS
Citation: Fl. Conceicao et al., Evidence-based approach to growth hormone replacement therapy in adults, with special emphasis on body composition, J PED END M, 13, 2000, pp. 1353-1358
Authors:
Pedersen, SB
Borglum, JD
Kristensen, K
Norrelund, H
Otto, J
Jorgensen, L
Richelsen, B
Citation: Sb. Pedersen et al., Regulation of uncoupling protein (UCP) 2 and 3 in adipose and muscle tissue by fasting and growth hormone treatment in obese humans, INT J OBES, 24(8), 2000, pp. 968-975
Citation: H. Norrelund et N. Moller, Muscle mass and function in thyrotoxic patients before and during medical treatment - Reply, CLIN ENDOCR, 53(4), 2000, pp. 541-541
Authors:
Norrelund, H
Borglum, J
Jorgensen, JOL
Richelsen, B
Moller, N
Nair, KS
Christiansen, JS
Citation: H. Norrelund et al., Effects of growth hormone administration on protein dynamics and substratemetabolism during 4 weeks of dietary restriction in obese women, CLIN ENDOCR, 52(3), 2000, pp. 305-312
Authors:
Richelsen, B
Pedersen, SB
Kristensen, K
Borglum, JD
Norrelund, H
Christiansen, JS
Jorgensen, JOL
Citation: B. Richelsen et al., Regulation of lipoprotein lipase and hormone-sensitive lipase activity andgene espression in adipose and muscle tissue by growth hormone treatment during weight loss in obese patients, METABOLISM, 49(7), 2000, pp. 906-911
Authors:
Norrelund, H
Vahl, N
Juul, A
Moller, N
Alberti, KGMM
Skakkebaek, NE
Christiansen, JS
Jorgensen, JOL
Citation: H. Norrelund et al., Continuation of growth hormone (GH) therapy in GH-deficient patients during transition from childhood to adulthood: Impact on insulin sensitivity andsubstrate metabolism, J CLIN END, 85(5), 2000, pp. 1912-1917
Authors:
Norrelund, H
Fisker, S
Vahl, N
Borglum, J
Richelsen, B
Christiansen, JS
Jorgensen, JOL
Citation: H. Norrelund et al., Evidence supporting a direct suppressive effect of growth hormone on serumIGFBP-1 levels. Experimental studies in normal, obese and GH-deficient adults, GROWTH H I, 9(1), 1999, pp. 52-60
Authors:
Norrelund, H
Hove, KY
Brems-Dalgaard, E
Jurik, AG
Nielsen, LP
Nielsen, S
Nielsen, S
Jorgensen, JOL
Weeke, J
Moller, N
Citation: H. Norrelund et al., Muscle mass and function in thyrotoxic patients before and during medical treatment, CLIN ENDOCR, 51(6), 1999, pp. 693-699
Authors:
Wolthers, T
Lechuga, A
Grofte, T
Norrelund, H
Moller, N
Christiansen, JS
Jorgensen, JOL
Citation: T. Wolthers et al., Serum leptin concentrations during short-term administration of growth hormone and triiodothyronine in healthy adults: A randomised, double-blind placebo-controlled study, HORMONE MET, 31(1), 1999, pp. 37-40
Authors:
Kristensen, K
Pedersen, SB
Fisker, S
Norrelund, H
Rosenfalck, AM
Jorgensen, JOL
Richelsen, B
Citation: K. Kristensen et al., Serum leptin levels and leptin expression in growth hormone (GH)-deficientand healthy adults: Influence of GH treatment, gender, and easting, METABOLISM, 47(12), 1998, pp. 1514-1519